• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Jefferies conference London queue 2026
Biotech

Biopharma gathers in London as M&A shines but China clouds loom

Executives and investors at London Life Sciences Week reflected on a busy year for M&A while weighing the potential impact of the COINS Act.
James Waldron Nov 20, 2026 8:40am
Merck  Co headquarters

Merck’s TROP2 ADC extends survival in pivotal cancer trial

Nov 20, 2026 11:20am
brain alzheimers dementia neuroscience gears thought think

Researchers uncover plastics in brains of patients with dementia

Nov 20, 2026 9:20am
Close-up of human eye

FDA delays Belite’s eye disease pill decision by 3 months

Nov 20, 2026 9:08am
Illustration for Fierces Chutes  Ladders feature showing a blue city skyline with executives making career moves o

Teva loses R&D head amid innovation revamp—Chutes & Ladders

Nov 20, 2026 8:30am
dart board miss failure

Bausch + Lomb and Celldex rocked by respective ph. 2 flops

Nov 20, 2026 5:20am
More News

Anthropic director Vas Narasimhan bets AI can speed Novartis R&D

Nov 19, 2026 5:31pm

Crown stays put as $204M Adicon deal falls through

Nov 19, 2026 4:55pm

Evaxion halts infectious disease work in R&D refocus on oncology

Nov 19, 2026 10:02am

nChroma halves headcount, halts trial of potential HBV ‘cure’

Nov 19, 2026 9:08am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings